APA citiranje

Montraveta, A., Lee-Vergés, E., Roldán, J., Jiménez, L., Cabezas, S., Clot, G., . . . Colomer, D. (2015). CD69 expression potentially predicts response to bendamustine and its modulation by ibrutinib or idelalisib enhances cytotoxic effect in chronic lymphocytic leukemia. Oncotarget.

Citação norma Chicago

Montraveta, Arnau, et al. "CD69 Expression Potentially Predicts Response to Bendamustine and Its Modulation By Ibrutinib or Idelalisib Enhances Cytotoxic Effect in Chronic Lymphocytic Leukemia." Oncotarget 2015.

MLA citiranje

Montraveta, Arnau, et al. "CD69 Expression Potentially Predicts Response to Bendamustine and Its Modulation By Ibrutinib or Idelalisib Enhances Cytotoxic Effect in Chronic Lymphocytic Leukemia." Oncotarget 2015.